Multiple Noninvasive Examination Modality to Evaluate the Severity of Ocular Surface Disorders
1 other identifier
observational
25
1 country
1
Brief Summary
Here the investigators proposed this study to collect cases of different etiologies of ocular surface diseases. With at least one of these four non-invasive examination modalities, the investigators aim to analyze and compare the detecting results. The investigators especially focus on the possibility of using OCT to predict the condition of limbal epithelial stem cells, aiming to use this patient-friendly tool to detect the patient's limbal conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2018
CompletedFirst Submitted
Initial submission to the registry
July 1, 2018
CompletedFirst Posted
Study publicly available on registry
July 20, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2019
CompletedJuly 26, 2019
May 1, 2019
8 months
July 1, 2018
July 24, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
limbal structural abnormality
atypical pattern of limbal Palisade of Vogt detected by OCT comparing to normal subjects
assess the OCT limbal image at the baseline
Study Arms (3)
control
Limbal image by OCT in normal subjects.
Advancing wave-like epitheliopathy
Limbal image by OCT in subjects with advancing wave-like epitheliopathy.
Ocular rosacea or phlyctenulosis
Limbal image by OCT in subjects with ocular rosacea or phlyctenulosis
Eligibility Criteria
Our study is an institutional observation study recruits otherwise healthy patients aging over 5 years old.
You may qualify if:
- Patient who is able to understand and cooperate with the examination: aged over 5 years.
- Patient or the legal representative is able to read and sign an informed consent form.
- Patient with one of the diagnosis listed below:
- limbal insufficiency
- phlyctenulosis
- ocular rosacea
- ocular graft-versus-host disease (GVHD)
- dry eye syndrome (both aqueous deficiency or increased evaporative forms of dry eyes)
- other ocular surface diseases (advancing wave-like epitheliopathy, long term use of anti-glaucoma eye drops)
You may not qualify if:
- Patients who decline to receive any of the non-invasive examinations mentions in this clinical trial.
- Patients younger than 5 years old.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NTUH
Taipei, Taiwan
Biospecimen
Impression cytology(IC) is a technique which permits the retrieval of the outermost layer of ocular surface cells via the use of various types of filters. It is a minimally invasive method of evaluating human conjunctival epithelial cell morphology. IC may also be utilized in the diagnosis of other ocular diseases, such as ocular surface squamous neoplasia, ocular surface infections, keratoconus and thyroid orbitopathy. IC improves our understanding of the pathophysiology of ocular surface disease, and provide biomarkers to be used as outcome measures in clinical trials.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Wei-Li Chen
NTUH
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2018
First Posted
July 20, 2018
Study Start
June 8, 2018
Primary Completion
January 31, 2019
Study Completion
May 22, 2019
Last Updated
July 26, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share